Indanazoline (as monohydrochloride active substance of Farial) is characterized by a pronounced vasoconstrictive action.
In animal experiments the new imidazoline derivative indanazoline (as monohydrochloride active substance of Farial) is characterized by a pronounced vasoconstrictive action after local or intravenous application[1].
[1]. Kretzschmar R, et al. [Pharmacology of N-(2-imidazolin-2-yl)-N-(4-indanyl)amino (indanazoline), a new vasoconstrictive imidazoline compound]. Arzneimittelforschung. 1980;30(10):1746-60.